USFDA warns Cadila Pharma over drug production processes
November 12, 2014 15:08 ISTNew Delhi: The US Food and Drug Administration (FDA) has sent a warning letter to Cadila Pharma over several manufacturing deficiencies at its Gujarat plant.In a letter issued on October 15, USFDA said inspectors in